Abstract CT094: Phase I study of fibroblast growth factor receptor 2 antibody-drug conjugate (FGFR2-ADC) BAY 1187982 in patients with advanced cancer
2017 ◽
Vol 35
(4)
◽
pp. 451-462
◽
2014 ◽
Vol 32
(15_suppl)
◽
pp. 11010-11010
◽
2019 ◽
Vol 25
(16)
◽
pp. 4888-4897
◽
2012 ◽
Vol 48
◽
pp. 191-192
◽